Overview
Chemring Group PLC is a UK-based company that operates internationally within the defense and security sectors. Founded in 1905, with headquarters in Romsey, Hampshire, England, the company specializes in the manufacture of technology-driven solutions for protection and safety. Chemring's primary operations focus on three core areas: countermeasures, sensors, and energetic systems. Key projects include manufacturing flares to protect aircraft, developing advanced technology for improvised explosive device detection, and creating propulsion systems for military missiles. Through ongoing research and development, Chemring aims to enhance the strengthening of national security by providing innovative, high-quality solutions critical to defense and security infrastructures globally.
Basic Stats
The share price of Chemring Group PLC as of 4 September 2025 is 540.00 GBX / share. This is an increase of 0.56% from the prior week. The market cap (or net worth) of Chemring Group PLC as of 5 September 2025 is 1,462.02 GBX MM.
The Factor Analysis chart (below right) shows a view of Chemring Group PLC from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,462.02 MM |
| EV | 1,540.91 MM |
| Shares Out. | 270.74 MM |
| Earnings Date | |
| EPS (TTM) | 0.16 |
| Dividend Yield | 1.28 % |
| Ex-Dividend Date | 2025-08-14 |
| Borrow Rate | 0.55 |
| Short Shares Avail. | 2.10 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 37.58 % |
| Volatility (1 yr) | 0.35 |
| Beta | 0.44 |
| Sharpe Ratio (1 yr) | 0.97 |
| Sortino Ratio (1 yr) | 1.63 |
| PE Ratio | 33.61 |
| Price/Book | 4.15 |
| Price/TBV | 6.43 |
| Book/Market | 0.24 |
| EBIT/EV | 0.04 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.06 |
| ROE | 0.12 |
| ROIC | 0.09 |
| CROIC | 0.06 |
| OCROIC | 0.17 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 68.76 /100 |
| Profitability | 80.50 /100 |
| Quality Score | 80.26 /100 |
| Value Score | 56.34 /100 |
| Momentum Score | 51.00 /100 |
| Stability (Low Vol) Score | 64.14 /100 |
| Analyst Sentiment | 59.99 /100 |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | 40.91 /100 |
| QVM Score | |
| Piotroski F-SCORE | 6.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Chemring Group PLC is 589.90 GBX. The forecasts range from a low of 494.90 GBX to a high of 703.50 GBX. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Chemring Group PLC. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-22 | Berenberg Bank | Buy | Reiterate | |
| 2022-10-06 | Berenberg Bank | Buy | Reiterate | |
| 2022-07-15 | Barclays | Underweight | Downgrade | |
| 2022-03-10 | Berenberg Bank | Buy | Reiterate | |
| 2022-02-16 | Berenberg Bank | Buy | Reiterate | |
| 2022-02-16 | Berenberg Bank | Reiteration | Reiterate | |
| 2022-02-09 | Barclays | Downgrade | Downgrade | |
| 2022-01-07 | Barclays | Reiteration | Reiterate | |
| 2021-12-14 | Berenberg Bank | Reiteration | Reiterate | |
| 2021-09-14 | Berenberg Bank | Buy | Reiterate | |
| 2021-06-03 | Berenberg Bank | Buy | Reiterate | |
| 2020-06-04 | Berenberg Bank | Buy | Reiterate | |
| 2017-07-05 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2017-06-23 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2017-01-30 | Canaccord Genuity | Buy | Upgrade | |
| 2017-01-20 | Liberum Capital | Buy | Reiterate | |
| 2017-01-20 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2017-01-05 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-11-22 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-11-22 | Canaccord Genuity | Hold | Reiterate | |
| 2016-09-01 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-09-01 | Canaccord Genuity | Hold | Reiterate | |
| 2016-07-20 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-06-23 | Canaccord Genuity | Hold | Downgrade | |
| 2016-06-16 | Canaccord Genuity | Buy | Reiterate | |
| 2016-04-14 | Panmure Gordon | Sell | Reiterate | |
| 2016-04-08 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-04-07 | Canaccord Genuity | Buy | Initiate | |
| 2016-03-30 | Panmure Gordon | Sell | Reiterate | |
| 2016-03-24 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2016-02-25 | Investec | Buy | Reiterate | |
| 2015-10-28 | Panmure Gordon | Sell | Reiterate | |
| 2015-10-27 | Panmure Gordon | Sell | Downgrade | |
| 2015-09-15 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2015-02-12 | Panmure Gordon | Buy | Reiterate | |
| 2015-01-22 | Liberum Capital | Hold | Reiterate | |
| 2015-01-22 | Investec | Buy | Reiterate | |
| 2015-01-15 | Espirito Santo Securities | Neutral | Reiterate | |
| 2015-01-12 | Investec | Buy | Reiterate | |
| 2014-12-19 | Barclays | Underweight | Reiterate | |
| 2014-11-26 | Liberum Capital | Hold | Reiterate | |
| 2014-11-26 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2014-11-26 | Espirito Santo Securities | Neutral | Upgrade | |
| 2014-11-26 | Canaccord Genuity | Hold | Reiterate | |
| 2014-11-25 | Liberum Capital | Hold | Reiterate | |
| 2014-11-25 | Investec | Buy | Upgrade | |
| 2014-11-19 | Westhouse Securities | Sell | Reiterate | |
| 2014-10-06 | Westhouse Securities | Sell | Reiterate | |
| 2014-09-25 | Westhouse Securities | Sell | Reiterate | |
| 2014-09-19 | Panmure Gordon | Buy | Reiterate | |
| 2014-09-19 | Canaccord Genuity | Hold | Upgrade | |
| 2014-09-17 | Investec | Add | Downgrade | |
| 2014-08-15 | Westhouse Securities | Sell | Reiterate | |
| 2014-08-13 | Panmure Gordon | Buy | Initiate | |
| 2014-07-23 | Investec | Buy | Reiterate | |
| 2014-07-22 | Westhouse Securities | Sell | Reiterate | |
| 2014-07-21 | Liberum Capital | Hold | Reiterate | |
| 2014-06-27 | Investec | Sell | Reiterate | |
| 2014-06-19 | Westhouse Securities | Sell | Initiate | |
| 2014-06-19 | Numis Securities | Buy | Reiterate | |
| 2014-06-12 | Citigroup | Neutral | Reiterate | |
| 2014-06-10 | Investec | Buy | Reiterate | |
| 2014-06-06 | UBS | Neutral | Reiterate | |
| 2014-03-20 | Liberum Capital | Sell | Downgrade | |
| 2014-03-05 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2014-02-28 | Barclays | Overweight | Reiterate | |
| 2014-02-27 | Investec | Buy | Reiterate | |
| 2014-02-05 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2014-01-24 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2014-01-24 | Citigroup | Neutral | Reiterate | |
| 2014-01-23 | Investec | Buy | Reiterate | |
| 2014-01-13 | Investec | Buy | Reiterate | |
| 2013-11-26 | JP Morgan Cazenove | Neutral | Reiterate | |
| 2013-11-25 | Investec | Buy | Upgrade | |
| 2013-10-17 | Citigroup | Neutral | Reiterate | |
| 2013-10-14 | Liberum Capital | Hold | Reiterate | |
| 2013-10-14 | JP Morgan Cazenove | Neutral | Downgrade | |
| 2013-10-09 | Barclays | Overweight | Upgrade | |
| 2013-09-18 | Investec | Add | Downgrade | |
| 2013-09-16 | Liberum Capital | Hold | Reiterate | |
| 2013-08-29 | UBS | Neutral | Reiterate | |
| 2013-08-29 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-08-28 | Investec | Buy | Reiterate | |
| 2013-07-09 | Espirito Santo Securities | Buy | Reiterate | |
| 2013-07-01 | Investec | Buy | Reiterate | |
| 2013-06-21 | Espirito Santo Securities | Buy | Reiterate | |
| 2013-06-19 | Liberum Capital | Hold | Reiterate | |
| 2013-06-19 | JP Morgan Cazenove | Overweight | Reiterate | |
| 2013-06-18 | Investec | Buy | Reiterate | |
| 2023-11-10 | Shore Capital | Buy | Reiterate | |
| 2023-12-18 | Shore Capital | Buy | Reiterate | |
| 2023-09-12 | Shore Capital | Buy | Reiterate | |
| 2023-11-13 | Berenberg Bank | Buy | Reiterate | |
| 2024-02-23 | Shore Capital | Buy | Reiterate | |
| 2024-06-04 | Shore Capital | Buy | Reiterate | |
| 2024-06-04 | Berenberg Bank | Buy | Reiterate | |
| 2024-05-07 | Barclays | Underweight | Reiterate | |
| 2024-06-18 | Deutsche | Buy | Reiterate | |
| 2024-12-17 | Jefferies | Buy | Reiterate | |
| 2025-02-25 | Shore Capital | Buy | Reiterate | |
| 2025-07-15 | Berenberg Bank | Buy | Reiterate |
